YaoGeJu

Company directoryChina company filings

Chengdu Aupone Pharmaceutical Co.,Ltd

As of 18 November 2026, for the company name Chengdu Aupone Pharmaceutical Co.,Ltd as recorded, the chemical-drug catalogue lists 6 active records with this name as holder; 25 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

23 acceptance records as first applicant, grouped into 12 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

西诺氨酯片 · No verified English name 3 records · Latest accepted 2026/05/08

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600869Supplement2026/05/08Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHB2600868Supplement2026/05/08Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHB2600867Supplement2026/05/08Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
瑞维那新吸入溶液 · No verified English name 1 records · Latest accepted 2026/02/04

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600357Generic2026/02/04Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Brivaracetam Solution for Injection 1 records · Latest accepted 2026/01/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600237Generic2026/01/21Chengdu Aupone Pharmaceutical Co.,Ltd; Chengdu Li Er Pharma Co., Ltd. romanizedCDE ↗
Brivaracetam Oral Solution 1 records · Latest accepted 2026/01/20

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600228Generic2026/01/20Chengdu Aupone Pharmaceutical Co.,Ltd; Chengdu Li Er Pharma Co., Ltd. romanizedCDE ↗
Brivaracetam Tablets 6 records · Latest accepted 2026/01/13

Generic · 6

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600146Generic2026/01/13Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHS2600145Generic2026/01/13Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHL2300134Generic2023/11/02Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHL2300133Generic2023/11/02Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHL2300098Generic2023/08/15Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHL2300097Generic2023/08/15Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Cariprazine hydrochloride Capsules 4 records · Latest accepted 2024/08/20

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2400169Generic2024/08/20Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHL2400168Generic2024/08/20Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHL2400125Generic2024/06/22Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHL2400124Generic2024/06/22Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Telmisartan And Amlodipine Tablets 1 records · Latest accepted 2024/03/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400882Generic2024/03/21Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
替米沙坦氨氯地平片(II) · No verified English name 1 records · Latest accepted 2024/03/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400881Generic2024/03/21Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Tandospirone Citrate Tablets 2 records · Latest accepted 2022/09/16

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201543Generic2022/09/16Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
CYHS2201542Generic2022/09/16Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Ferrous Succinate Tablets 1 records · Latest accepted 2022/06/28

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250397Supplement2022/06/28Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
硫酸特布他林雾化吸入用溶液 · No verified English name 1 records · Latest accepted 2022/01/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200172Generic2022/01/25Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Terbinafine Hydrochloride Tablets 1 records · Latest accepted 2021/05/26

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150629Supplement2021/05/26Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗

Changes in the last 90 days

4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Notification delivery: 4 applications

  1. 2026/11/04Notification delivery

    Brivaracetam Solution for Injection

    CYHS2600237

    Fact date: 2026/11/04 (Publication date) · Publication date: 2026/11/04 · Date added to this site: 2026/11/04

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 14 ↗
  2. 2026/11/04Notification delivery

    Brivaracetam Oral Solution

    CYHS2600228

    Fact date: 2026/11/04 (Publication date) · Publication date: 2026/11/04 · Date added to this site: 2026/11/04

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 13 ↗
  3. 2026/10/28Notification delivery

    Brivaracetam Tablets

    CYHS2600146

    Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Date added to this site: 2026/11/03

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 19 ↗
  4. 2026/10/28Notification delivery

    Brivaracetam Tablets

    CYHS2600145

    Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Date added to this site: 2026/11/03

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 18 ↗

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
西诺氨酯片 · No verified English name CYHB2600869Supplement2026/05/08Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
西诺氨酯片 · No verified English name CYHB2600868Supplement2026/05/08Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
西诺氨酯片 · No verified English name CYHB2600867Supplement2026/05/08Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
瑞维那新吸入溶液 · No verified English name CYHS2600357Generic2026/02/04Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗

Catalogue holder records

6 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Tandospirone Citrate TabletsChengdu Aupone Pharmaceutical Co.,LtdChengdu Aupone Pharmaceutical Co.,Ltd国药准字H202444912024/07/30Generic approved under the new chemical-drug registration classificationCDE ↗
Tandospirone Citrate TabletsChengdu Aupone Pharmaceutical Co.,LtdChengdu Aupone Pharmaceutical Co.,Ltd国药准字H202444922024/07/30Generic approved under the new chemical-drug registration classificationCDE ↗
Ferrous Succinate TabletsChengdu Aupone Pharmaceutical Co.,LtdChengdu Aupone Pharmaceutical Co.,Ltd国药准字H200830032023/08/02Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Terbinafine Hydrochloride TabletsChengdu Aupone Pharmaceutical Co.,LtdChengdu Aupone Pharmaceutical Co.,Ltd国药准字H200941332022/07/13Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Sertraline Hydrochloride TabletsChengdu Aupone Pharmaceutical Co.,LtdChengdu Aupone Pharmaceutical Co.,Ltd国药准字H200603832021/06/08Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Telmisartan And Amlodipine TabletsChengdu Aupone Pharmaceutical Co.,LtdChengdu Aupone Pharmaceutical Co.,Ltd国药准字H202553792025/09/09Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

25 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
布立西坦 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20260000747I2026/09/09CDE ↗
甲苯磺酸卢美哌隆 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20260000307I2026/05/09CDE ↗
瑞维那新 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20250001481I2026/01/07CDE ↗
右莰醇 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20250000284A2026/08/18CDE ↗
阿伐那非 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20240001203A2026/08/15CDE ↗
苯巴那酯 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20240000878I2024/10/10CDE ↗
盐酸兰地洛尔 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20240000701A2026/02/25CDE ↗
蛋白琥珀酸铁 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20240000317A2026/03/13CDE ↗
盐酸乌拉地尔 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20230000550A2025/05/08CDE ↗
盐酸卡利拉嗪 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20230000044I2023/04/06CDE ↗
布立西坦 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20230000092I2023/03/22CDE ↗
枸橼酸坦度螺酮 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20220000586A2026/09/16CDE ↗
磺达肝癸钠 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20210001161A2026/11/04CDE ↗
硫酸特布他林 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20210000786A2023/12/13CDE ↗
琥珀酸普芦卡必利 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20200000188A2026/09/21CDE ↗
氯雷他定 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190008149A2025/12/26CDE ↗
盐酸甲氯芬酯 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190006734A2023/03/24CDE ↗
盐酸特比萘芬 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190005893A2025/09/16CDE ↗
盐酸米多君 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190005892A2025/09/04CDE ↗
盐酸小檗碱 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190005748A2025/12/26CDE ↗
琥珀酸亚铁 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190005747A2025/09/16CDE ↗
盐酸舍曲林 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190004755A2026/06/12CDE ↗
盐酸西替利嗪 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190002122A2026/02/05CDE ↗
西洛他唑 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190002120A2025/05/10CDE ↗
鞣酸苦参碱 · No verified English nameChengdu Aupone Pharmaceutical Co.,LtdY20190002118A2025/05/08CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

8 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
瑞维那新吸入溶液 · No verified English name CYHS2600861Generic2026/04/15Zhejiang Fu Rui Xi Pharma Co., Ltd. romanized; Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
瑞维那新吸入溶液 · No verified English name CYHS2600630Generic2026/03/09Chongqing Kang Ke Er Pharmaceutical Co., Ltd. romanized; Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
西诺氨酯片 · No verified English name CYHS2504450Generic2025/12/27Sichuan Ao Bang Gu De Pharma Co., Ltd. romanized; Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
西诺氨酯片 · No verified English name CYHS2504449Generic2025/12/27Sichuan Ao Bang Gu De Pharma Co., Ltd. romanized; Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
西诺氨酯片 · No verified English name CYHS2504448Generic2025/12/27Sichuan Ao Bang Gu De Pharma Co., Ltd. romanized; Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Formoterol Fumarate Inhalation Solution CYHB2502098Supplement2025/10/17Heilongjiang Xian Dong Pharma Co., Ltd. romanized; Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Formoterol Fumarate Inhalation Solution CYHS2302404Generic2023/09/07Chengdu Mi Zi Biopharmaceuticals Technology Co., Ltd. romanized; Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗
Ursodeoxycholic Acid Capsules CYHS2101364Generic2021/06/29Name not romanized; Chengdu Aupone Pharmaceutical Co.,LtdCDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.